ЭПИДЕМИОЛОГИЧЕСКАЯ ХАРАКТЕРИСТИКА ВРОЖДЕННОЙ КАТАРАКТЫ. ОБЗОР ЛИТЕРАТУРЫ
Введение: Врожденная катаракта является одной из основных причин инвалидности по зрению с детства. По данным литературына долю врожденных катаракт приходится от 10 до 19,5%среди причин слепоты и слабовидения Проведение эпидемиологических исследований является первым шагом к планированию распределения ресурсов сектора здравоохранения и уменьшению бремени предотвратимой слепоты вследствие врожденной катаракты. Цель исследования: изучить эпидемиологические характеристики врожденной катаракты, а также отразить статистические данные Алматинского городского филиала РГП на ПХВ «Республиканский центр электронного здравоохранения» МЗ РК по заболеваемости врожденной катарактой у детей по городу Алматы и количеству детей 0-17 лет, состоящих на диспансерном учете с диагнозом «Катаракта» в Республике Казахстан. Стратегия поиска: поиск литературы был осуществлен в электронных базах MEDLINE, PubMed, EMBASE, Web of Science, Google Scholar и e-library, по ключевым словам (врожденная катаракта; дети; распространенность; заболеваемость). Глубина поиска составила 25 лет (с 1996 по 2021 годы). Релевантные работы, отражающие характеристики проблемы, были приняты для описания в обзоре. Из всех отобранных статей для последующего анализа было включено 71 источник, которые отвечали критериям включения и исключали дублирование или повтор информации. Результаты и выводы: 1. Распространенность и заболеваемость врожденной катарактой значительно варьирует в мире. 2. Многие эпидемиологические исследования указывают на более частую встречаемость данной патологии среди мальчиков. 3. Чаще встречается двусторонняя форма врожденной катаракты, а среди клинико-морфологических форм: диффузная, ядерная и задняя субкапсулярная формы. 4. По данным Алматинского городского филиала РГП на ПХВ «Республиканский центр электронного здравоохранения» МЗ РК отмечается рост заболеваемости детей врожденной катарактой по городу Алматы, а также увеличение количества детей 0-17 лет, состоящих на диспансерном учете с диагнозом «Катаракта» в Республике Казахстан. Ключевые слова: врожденная катаракта, дети, распространенность, заболеваемость.
Алия К. Кабылбекова1, Алтын М. Арингазина2, Ардак М. Ауезова1, Серик К. Мейрманов3 1 Казахстанский медицинский университет «Высшая школа общественного здравоохранения», г. Алматы, Республика Казахстан; 2 Международная школа медицины Каспийского университета, г. Алматы, Республика Казахстан; 3 Ритцумейкан Азиатско-Тихоокеанский университет, г. Беппу, Япония.
1. Abrahamsson M. et al. The occurrence of congenital cataract in western Sweden // Acta Ophthalmol. Scand. 1999. 77, 5, 578–580. https://doi.org/10.1034/j.1600-0420.1999.770520.x. 2. Aubakirova А.Z. Study of clinical features and development of treatment methods for children with congenital eye diseases in Kazakhstan: diss. doc.med.sci: 14.00.09, 14.00.08.- Almaty, 1996. 240р. 3. Churchill A., Graw J. Clinical and experimental advances in congenital and paediatric cataracts // Philos. Trans. R. Soc. B Biol. Sci. 2011.366, 1568, 1234–1249 https://doi.org/10.1098/rstb.2010.0227. 4. Dewan Pooja Gupta Burden of Congenital Rubella Syndrome (CRS) in India: Indian Pediatr. 49, May,2012,2012.377–399 5. Egijan N.S. et al. The role of the pediatrician in the treatment of children with congenital cataracts // Russ. Bull. Perinatol. Pediatr. 2019.64, 5, 134–139. https://doi.org/10.21508/1027–4065–2019–64–5–134–139. 6. Fakhoury O. et al. Epidemiologic and etiological characteristics of congenital cataract: Study of 59 cases over 10 years // J. Fr. D Ophtalmol. 2015. 38, 4, 295–300 https://doi.org/10.1016/j.jfo.2014.10.012. 7. Fox A. et al. A follow-on study on vision-related quality of life assessment using the NEI-VFQ-25 in those with a history of unilateral and bilateral congenital cataracts // Acta Ophthalmol. 2018. 96, 5, E596–E599. https://doi.org/10.1111/aos.13692. 8. Gao Y. et al. Novel OCRL1 gene mutations in six Chinese families with Lowe syndrome // World J. Pediatr. 12, 4, 484–488 (2016). https://doi.org/10.1007/s12519-016-0017-y. 9. Gilbert C., Foster A. Childhood blindness in the context of VISION 2020 - The right to sight // Bull. World Health Organ. 2001.79, 3, 227–232 https://doi.org/10.1590/S0042-96862001000300011. 10. Gillespie R.L. et al. Next-generation Sequencing in the Diagnosis of Metabolic Disease Marked by Pediatric Cataract // Ophthalmology. 2016. 123, 1, 217–220. https://doi.org/10.1016/j.ophtha.2015.06.035. 11. Haargaard B. et al. A nationwide Danish study of 1027 cases of congenital/infantile cataracts: Etiological and clinical classifications // Ophthalmology. 2004.111, 12, 2292–2298. https://doi.org/10.1016/j.ophtha.2004.06.024. 12. Haargaard B. et al. Incidence and cumulative risk of childhood cataract in a cohort of 2.6 million Danish children. Investig // Ophthalmol. Vis. Sci.2004. 45, 5, 1316–1320 https://doi.org/10.1167/iovs.03-0635. 13. Holmes J.M. et al. Birth prevalence of visually significant infantile cataract in a defined U.S. population // Ophthalmic Epidemiol. 2003. 10, 2, 67–74 https://doi.org/10.1076/opep.10.2.67.13894. 14. Ilarslan E. et al.: Cataract in a Preterm Newborn: A Possible Side Effect of Linezolid Therapy // Jcpsp-Journal Coll. Physicians Surg. Pakistan. 2014. 24, S281–S283 https://doi.org/11.2014/JCPSP.S281S283. 15. Jyoti M. et al. Congenital rubella syndrome: Global issue // J. Cataract Refract. Surg. 2015.41, 5, 1127 https://doi.org/10.1016/j.jcrs.2015.04.021. 16. Kabylbekova А.К. et al. Epidemiology, etiology and screening of congenital cataracts // Cent. Asian Sci. Pract. J. Public Heal. 2020, 3, 70–76. 17. Katargina L.А., Mikhailova L.А. Status of pediatric ophthalmological service in the Russian Federation (2012-2013) // Russ. Pediatr. Ophthalmol. 2015.№1, 5–10. 18. Khosravi, A. et al. A case of Marfan’s syndrome with multi-level aortic dissections. ARYA Atheroscler. 2014. 10, 6. 334–338. 19. Knowles R.L. et al. Patient-reported quality of life outcomes for children with serious congenital heart defects // Arch. Dis. Child. 2014. 99, 5, 413–419 https://doi.org/10.1136/archdischild-2013-305130. 20. Kondo H. et al. Familial acorea, microphthalmia and cataract syndrome // Br. J. Ophthalmol. 2013. 97, 9, 1155–1160. https://doi.org/10.1136/bjophthalmol-2013-303165. 21. Krasilnikova V.L. The structure of eye pathology among the pediatric population of the Republic of Belarus. Ophthalmol // East. Eur. 2012. №3 (14), 105–109. 22. Kruglova, T.B., Hvatova, А.V.: Classification of congenital cataracts // Russ. Pediatr. Ophthalmol. 2013. 2, 4–11. 23. Kumar D. et al. A link between maternal malnutrition and depletion of glutathione in the developing lens: A possible explanation for idiopathic childhood cataract? // Clin. Exp. Optom. 2013. 96, 6, 523–528. https://doi.org/10.1111/cxo.12076. 24. Lambert S.R., Drack A.V. Infantile cataracts // Surv. Ophthalmol. 1996. 40, 6, 427–458. https://doi.org/10.1016/S0039-6257(96)82011-X. 25. Lee A.Y.W. et al. Demonstration that polyol accumulation is responsible for diabetic cataract by the use of transgenic mice expressing the aldose reductase gene in the lens // Proc. Natl. Acad. Sci. U. S. A. 1995. 92, 7, 2780–2784. https://doi.org/10.1073/pnas.92.7.2780. 26. Legge G.E., Chung S.T.L. Low Vision and Plasticity: Implications for Rehabilitation // Annu. Rev. Vis. Sci. 2016. 2, 321–343. https://doi.org/10.1146/annurev-vision-111815-114344. 27. Leng X.Y. et al. Congenital microcornea-cataract syndrome-causing mutation X253R increases βb1-crystallin hydrophobicity to promote aggregate formation // Biochem. J. 2016.473, 14, 2087–2096. https://doi.org/10.1042/BCJ20160247. 28. Lenhart P. et al.: Global Challenges in the Management of Congenital Cataract: in HHS Public Access // J Aapos. 2014. 19, 2, 1–8. https://doi.org/10.1016/j.jaapos.2015.01.013.Global. 29. Li J. et al. Screening, genetics, risk factors, and treatment of neonatal cataracts, 2017. https://doi.org/10.1002/bdr2.1050. 30. Lim Z. et al. Pediatric Cataract: The Toronto Experience-Etiology // Am. J. Ophthalmol.2010 149, 6, 887–892. https://doi.org/10.1016/j.ajo.2010.01.012. 31. De Lima S. et al. Congenital cataract in newborns: A qualitative study on parents’ experiences of the surgery and subsequent care // Acta Ophthalmol. 2020.98, 6, 585–591 https://doi.org/10.1111/aos.14407. 32. Lin H. et al. Congenital Cataract: Prevalence and Surgery Age at Zhongshan Ophthalmic Center (ZOC) // PLoS One. 2014.9, 7, 101781. https://doi.org/10.1371/journal.pone.0101781. 33. Magnusson G. et al. The Paediatric Cataract Register (PECARE): an overview of operated childhood cataract in Sweden and Denmark // Acta Ophthalmol. 2018. 96, 1, 51–55. https://doi.org/10.1111/aos.13497. 34. Mc Loone E. et al. TORCH testing in non-familial paediatric cataract. Eye. 2016. 30, 9, 1275–1276. https://doi.org/10.1038/eye.2016.153. 35. Medsinge A., Nischal K.K. Pediatric cataract: Challenges and future directions // Clin. Ophthalmol. 2015. 9, 77–90. https://doi.org/10.2147/OPTH.S59009. 36. Mohammadpour M. et al. Updates on managements of pediatric cataract // J. Curr. Ophthalmol. 2019. 31, 2, 118–126. https://doi.org/10.1016/j.joco.2018.11.005. 37. Moreau K.L., King J.A. Protein misfolding and aggregation in cataract disease and prospects for prevention, 2012.https://pubmed.ncbi.nlm.nih.gov/22520268/,https://doi.org/10.1016/j.molmed.2012.03.005. 38. Morikawa S. et al. A novel heterozygous mutation of the WFS1 gene leading to constitutive endoplasmic reticulum stress is the cause of Wolfram syndrome // Pediatr. Diabetes. 2017. 18, 8, 934–941. https://doi.org/10.1111/pedi.12513. 39. Nagamoto T. et al. Clinical characteristics of congenital and developmental cataract undergoing surgical treatment // Jpn. J. Ophthalmol. 2015. 59, 3, 148–56 https://doi.org/10.1007/s10384-015-0370-8. 40. Olusanya B.A. et al. Age at detection and age at presentation of childhood cataract at a tertiary facility in Ibadan, Southwest Nigeria // Bmc Ophthalmol. 2020.20, 1, https://doi.org/10.1186/s12886-020-1323-7. 41. Pasyanthi B. et al. Ophthalmologic manifestations of Hallermann-Streiff-Francois syndrome: Report of four cases // Eye. 2016. 30, 9, 1268–1271. https://doi.org/10.1038/eye.2016.161. 42. Pi L.H. et al. Prevalence of Eye Diseases and Causes of Visual Impairment in School-Aged Children in Western China // J. Epidemiol. 2012. 22, 1, 37–44. https://doi.org/10.2188/jea.JE20110063. 43. Prasov L. et al. ATOH7 mutations cause autosomal recessive persistent hyperplasia of the primary vitreous // Hum. Mol. Genet. 2012. 21, 16, 3681–3694. https://doi.org/10.1093/hmg/dds197. 44. Rahi J.S., Dezateux, C. Congenital and infantile cataract in the United Kingdom: Underlying or associated factors // Investig. Ophthalmol. Vis. Sci. 41, 8, 2108–2114 (2000). 45. Rahi J.S., Dezateux C. Measuring and interpreting the incidence of congenital ocular anomalies: Lessons from a national study of congenital cataract in the UK // Investig. Ophthalmol. Vis. Sci. 2001.42, 7, 1444–1448 46. Rahi J.S., Dezateux C. National cross sectional study of detection of congenital and infantile cataract in the United Kingdom: Role of childhood screening and surveillance // Br. Med. J. 1999. 318, 7180, 362–365. https://doi.org/10.1136/bmj.318.7180.362. 47. Rajappa M. et al. Inherited metabolic disorders involving the eye: A clinico-biochemical perspective // Eye. 2010.24, 4, 507–518 https://doi.org/10.1038/eye.2009.229. 48. Raum C. et al. The Meaning of Galactose Metabolism for Congenital Cataract - A 12-Year Analysis // Invest. Ophthalmol. Vis. Sci. 2010.51, 13. 49. Santana A., Waiswol M. The genetic and molecular basis of congenital cataract // Arq. Bras. Oftalmol. 2011. 74, 2, 136–142. https://doi.org/10.1590/S0004-27492011000200016. 50. Self J.E. et al. Cataract management in children: a review of the literature and current practice across five large UK centres // Eye. 2020. 34, 12, 2197–2218. https://doi.org/10.1038/s41433-020-1115-6. 51. Shalaby, A.K. et al.: Identification and functional analysis of a novel oculocerebrorenal syndrome of lowe (Ocrl) gene variant in two pedigrees with varying phenotypes including isolated congenital cataract. Mol. Vis. 24, June, 847–852 (2018). 52. Sheeladevi S. et al. Delay in presentation to hospital for childhood cataract surgery in India // Eye.2018. 32, 12, 1811–1818. https://doi.org/10.1038/s41433-018-0176-2. 53. Sheeladevi S. et al. Global prevalence of childhood cataract: A systematic review // Eye. 2016. 30, 9, 1160–1169. https://doi.org/10.1038/eye.2016.156. 54. Shiels A. et al. Cat-Map: Putting cataract on the map // Mol. Vis. 16, October 2010, 2007–2015. 55. Shirley K. et al. Impact of healthcare strategies on patterns of paediatric sight impairment in a developed population: 1984-2011 // Eye. 2017. 31, 11, 1537–1545. https://doi.org/10.1038/eye.2017.206. 56. Shore R.E. et al. Epidemiological studies of cataract risk at low to moderate radiation doses: (Not) seeing is believing. Radiat. Res. 2010. 174, 6 B, 889–894. https://doi.org/10.1667/RR1884.1. 57. Singh M.P. et al.: Infectious agents in congenital cataract in a tertiary care referral center in North India // Diagn. Microbiol. Infect. Dis. 2016. 85, 4, 477–481. https://doi.org/10.1016/j.diagmicrobio.2016.05.007. 58. Singh V.M. et al. Profile of congenital cataract in the first year of life from a tertiary care center in South India - A modern series // Indian J. Ophthalmol. 2021. 69, 4, 932–936. https://doi.org/10.4103/ijo.IJO_1558_20. 59. Solebo A.L. et al. 5-year outcomes after primary intraocular lens implantation in children aged 2 years or younger with congenital or infantile cataract: findings from the IoLunder2 prospective inception cohort study // Lancet Child Adolesc. Heal. 2018. 2, 12, 863–871. https://doi.org/10.1016/S2352-4642(18)30317-1. 60. Solebo A.L. et al. Epidemiology of blindness in children // Arch. Dis. Child. 2017. 102, 9, 853–857. https://doi.org/10.1136/archdischild-2016-310532. 61. Steinkellner H. et al. Identification and molecular characterisation of a homozygous missense mutation in the ADAMTS10 gene in a patient with Weill-Marchesani syndrome // Eur. J. Hum. Genet. 2015. 23, 9, 1186–1191. https://doi.org/10.1038/ejhg.2014.264. 62. Tadros D. et al. Primary versus secondary IOL implantation following removal of infantile unilateral congenital cataract: outcomes after at least 5 years // J. Aapos. 2016. 20, 1, 25–29. https://doi.org/10.1016/j.jaapos.2015.10.010. 63. Tailor V.K. et al. Quality of life and functional vision in children treated for cataract—a cross-sectional study. 2017. https://doi.org/10.1038/eye.2016.323. 64. Teleuova Т.S.Congenital pathology of the lens // Bull. Almaty State Inst. Postgrad. Med. Educ. 2009. №1(10), 41–46. 65. Tian Q. et al. A novel NHS mutation causes Nance-Horan Syndrome in a Chinese family // BMC Med. Genet. 2017. 18, 1, 4–9. https://doi.org/10.1186/s12881-016-0360-9. 66. Wirth M.G. et al. Aetiology of congenital and paediatric cataract in an Australian population // Br. J. Ophthalmol. 2002. 86, 7, 782–786. https://doi.org/10.1136/bjo.86.7.782. 67. Wu X. et al. Prevalence and epidemiological characteristics of congenital cataract: a systematic review and meta-analysis // Sci. Rep. 2016. 6, 1, 28564. https://doi.org/10.1038/srep28564. 68. Xiao B. et al. Using key informant method to assess the prevalence and causes of childhood blindness in Xiu’shui County, Jiangxi Province, Southeast China // Ophthalmic Epidemiol. 2011. 18, 1, 30–35. https://doi.org/10.3109/09286586.2010.528138. 69. You C.Y. et al.Visual impairment and delay in presentation for surgery in Chinese pediatric patients with cataract // Ophthalmology. 2011. 118, 1, 17–23. https://doi.org/10.1016/j.ophtha.2010.04.014. 70. Zhang X. et al. Large novel deletions detected in Chinese families with aniridia: Correlation between genotype and phenotype // Mol. Vis. 2011. 17, September 2010, 548–557. 71. Zhu X. et al. Clinical Features of Congenital and Developmental Cataract in East China: A Five-year Retrospective Review // Sci. Rep. 2017. 7, 1, 1–5. https://doi.org/10.1038/s41598-017-04332-1.
Количество просмотров: 80

Ключевые слова:

Библиографическая ссылка

Kabylbekova A.K., Aringazina A.M., Auyezova A.M., Meirmanov S.K. Epidemiological characteristics of congenital cataract. Literature review // Nauka i Zdravookhranenie [Science & Healthcare]. 2022, (Vol.24) 3, pp. 219-226. doi 10.34689/SH.2022.24.3.025 Кабылбекова А.К., Арингазина А.М., Ауезова А.М., Мейрманов С.К. Эпидемиологическая характеристика врожденной катаракты. Обзор литературы // Наука и Здравоохранение. 2022. 3(Т.24). С. 219-226. doi 10.34689/SH.2022.24.3.025 Кабылбекова А.К., Арингазина А.М., Ауезова А.М., Мейрманов С.К. Tyaбіткен катарактаның эпидемиологиялық сипаттамасы. Әдеби шолу // Ғылым және Денсаулық сақтау. 2022. 3 (Т.24). Б. 219-226. doi 10.34689/SH.2022.24.3.025

Авторизируйтесь для отправки комментариев